CDC Candidemia Statistics: The Trend Raising Eyebrows
CDC candidemia statistics show that candidemia remains a major, costly bloodstream infection in the United States: CDC-linked analyses estimate about 25,000 cases per year and an incidence around 7 cases per 100,000 population during 2017-2021, with highest rates in older adults.
Below, you'll find the key surveillance findings, the numbers experts use to judge trend direction, and why analysts say the problem is still "not solved" even when the headline incidence seems stable.
What the CDC data say (latest)
CDC's candidemia statistics package summarizes that an estimated 25,000 cases occur each year in the U.S., and that candidemia incidence declined earlier (2008-2013) before staying roughly around 7 cases per 100,000 during 2017-2021.
In a population-based candidemia surveillance study of culture-confirmed cases, investigators estimated that candidemia incidence during the covered period was about 7 per 100,000 overall, with higher burdens in adults aged 65+ (around 20 per 100,000) and differences by sex and race.
- Estimated burden (annual, U.S.): about 25,000 candidemia cases per year.
- Incidence level (U.S., 2017-2021): approximately 7 cases per 100,000 population overall.
- High-risk age group: adults 65+ have the highest incidence (about 20 per 100,000 in 2017 estimates).
Core numbers you can cite
If you need quote-ready statistics for reporting or briefings, CDC-linked estimates often anchor on a national case estimate and an incidence rate, then break down which groups carry the highest rates.
One widely cited CDC-associated analysis estimated that 22,660 candidemia cases occurred in 2017 (with a 95% confidence interval of 20,210-25,110), corresponding to an overall incidence of 7.0 per 100,000, with the highest incidence among people aged 65+ (20.1 per 100,000).
- 2017 national case estimate: 22,660 cases (95% CI: 20,210-25,110).
- Overall incidence (2017): 7.0 per 100,000 population.
- Highest subgroup (2017): adults ≥65 years at 20.1 per 100,000.
- CDC trend framing: incidence stayed ~9 per 100,000 during 2012-2016, then ~7 per 100,000 during 2017-2021.
Illustrative statistics table
The table below uses the CDC-published incidence framing and a 2017 subgroup breakdown to show how incidence rates can differ across groups-even when the national headline looks "steady."
| Time window | Metric | CDC-linked estimate (U.S.) | What it means |
|---|---|---|---|
| 2017 | Estimated cases | 22,660 (95% CI 20,210-25,110) | Modeled national candidemia burden from population-based surveillance. |
| 2017 | Overall incidence | 7.0 per 100,000 | National average risk across the population. |
| 2017 | Incidence, age 65+ | 20.1 per 100,000 | Older adults carry a much higher rate of candidemia. |
| 2017-2021 | Incidence trend framing | Approximately 7 per 100,000 per year | Overall incidence remained around this level during these years. |
| Annual (CDC summary) | Estimated cases | ~25,000 cases/year | CDC's headline estimate of the ongoing burden. |
Why experts remain concerned
Even when overall incidence appears stable, clinicians and public-health teams stay focused because candidemia continues to cause severe illness, healthcare disruption, and meaningful mortality; plus, species-level and resistance patterns can shift without dramatically changing the headline number.
Expert concern is also driven by the mismatch between national averages and the real risk concentrated in higher-risk populations-particularly older adults-meaning prevention failures or delays can still translate into large numbers of bloodstream infections.
"Surveillance helps assess the impact of prevention interventions," because without ongoing monitoring, it becomes harder to know whether a stable average reflects true progress or simply offsetting changes across hospitals and patient groups.
How the CDC surveillance estimates are built
The credibility of CDC candidemia statistics is strengthened by the way surveillance sites identify culture-confirmed cases and then use weighted methods to estimate national burden, rather than assuming the participating hospitals perfectly mirror the whole country.
In the 2017 burden analysis, researchers identified cases across multiple surveillance sites and then estimated national totals using sampling weights and demographic stratification, producing modeled national case counts and confidence intervals.
Historical context that explains the shape of trends
CDC's candidemia statistics page frames a decline followed by plateau: incidence declined during 2008-2013, then remained around 9 cases per 100,000 during 2012-2016, and then was approximately 7 cases per 100,000 during 2017-2021.
This history matters for interpretation: a plateau can still mask changes in patient mix, ICU practices, antifungal use, and pathogen distribution-so analysts treat "stable" as a prompt to look deeper rather than a reason to step back.
FAQ
Reporting checklist for your next draft
If you're writing for a general audience, build credibility by pairing a national estimate with a subgroup risk point, and then explicitly state the time window the numbers come from.
- State the time window (e.g., 2017 or 2017-2021) immediately after the number.
- Include at least one incidence rate and one high-risk subgroup (e.g., 65+).
- Explain-briefly-what "incidence stability" does and doesn't tell you.
Key concerns and solutions for Cdc Candidemia Statistics The Trend Raising Eyebrows
What is candidemia?
Candidemia is a bloodstream infection caused by Candida yeasts entering the bloodstream, which makes it a serious invasive fungal disease.
How many candidemia cases does CDC estimate each year?
CDC's candidemia statistics summary estimates about 25,000 candidemia cases occur each year in the United States.
What were the CDC-linked incidence levels during 2017-2021?
CDC's summary indicates overall candidemia incidence was approximately 7 cases per 100,000 population per year during 2017-2021.
Which group has the highest candidemia incidence?
In CDC-linked 2017 estimates, incidence was highest among adults aged 65 years and older, at about 20.1 cases per 100,000 population.
Are trends improving or just stable?
CDC's summary shows a meaningful decline earlier (2008-2013) followed by a plateau phase, so the key question for experts is whether stability reflects sustained progress or offsetting changes across populations and pathogens.